Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Antimicrob Chemother ; 55(5): 628-33, 2005 May.
Article in English | MEDLINE | ID: mdl-15772143

ABSTRACT

Progress on rational intervention to prevent increasing antibiotic resistance has been slow. We suggest that this is because the science of resistance epidemiology has received little attention, and that a systematic, co-operative investigation of this area might yield a relevant knowledge base, analogous to the basis for effective public health intervention in infectious disease given by infection epidemiology. The steps required to progress this approach in the UK are discussed, along with a summary of what is known and speculation on what might emerge.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Infections/epidemiology , Drug Resistance, Bacterial , Population Surveillance/methods , Adolescent , Aged , Bacteria/drug effects , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Child , Child, Preschool , Humans , Infant , Prevalence , Research Design , United Kingdom
2.
J Antimicrob Chemother ; 53(6): 1010-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15102750

ABSTRACT

OBJECTIVE: To investigate the effects of laboratory testing policies, particularly selective testing, rule-based reporting and isolate identification, on estimates of community antimicrobial resistance. MATERIALS AND METHODS: Antibiotic resistance estimates were analysed from an all-Wales dataset for approximately 300 000 community isolates of common pathogens. RESULTS: Selective testing policies were often associated with markedly increased resistance, particularly for second-line testing. Site-specific testing tended to yield variant resistance estimates for eye and ear isolates. Estimates from rule-based reporting deviated markedly from test-result-based reporting. Urinary isolates reported as Escherichia coli showed greater susceptibility than those reported as undifferentiated urinary 'coliforms'. The proportion of isolates tested for an antibiotic by a laboratory was a useful indicator of selective testing in this dataset. Selective testing policies had invariably been applied where the proportion of isolates of a species tested against an antibiotic was <90%. As this proportion fell with increasingly selective policies, divergence from pooled-all-Wales non-selective estimates tended to increase, with a bias to increased resistance. CONCLUSIONS: Selective testing, rule-based reporting and urinary coliform identification policies all had significant effects upon resistance estimates. Triage based upon the proportion of isolates tested seemed a useful tool in assigning analysis resources. Where <20% of isolates were tested, selective policies with inherent bias to increased resistance were common, the low number of isolates gave high potential sampling errors, and little confidence could be placed in the resistance estimate. Where 20-90% of isolates were tested, detailed analysis sometimes revealed resistance estimates that might be usefully retrieved. Where >/=90% of isolates were tested, there was no evidence of selective testing, and inter-laboratory variation in estimates appeared to be safely ascribable to other effects, e.g. methodology or real variation in resistance levels.


Subject(s)
Drug Resistance, Bacterial , Laboratories/standards , Microbial Sensitivity Tests/standards , Population Surveillance/methods , Anti-Bacterial Agents/pharmacology , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Drug Prescriptions , Enterobacteriaceae , Humans , Public Policy , Urinary Tract Infections/microbiology , Wales/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...